Initial Webinar Details
You are invited to watch a recorded webinar session where presenters from medSask and the Saskatchewan Drug Plan and Extended Benefits Branch will review the use of Biosimilar drugs, and describe the Saskatchewan Biosimilars Initiative and the role of pharmacists and primary care providers in transitioning patients to biosimilar insulin.
Speakers:
- Janice Norfield, BSP, medSask
- Chantal Mougeot, BSP, Drug Plan and Extended Benefits Branch, Ministry of Health.
Target Audience: All Saskatchewan Health Care providers are invited to attend.
Date: Webinar recorded on February 16, 2023.
Accredited by CPDPP: for 1.5 CEUs
Cost: n/a
Register below to view the recording.
Recorded Q&A Session
Presenters from medSask and the Saskatchewan Drug Plan and Extended Benefits Branch discuss and answer questions posed by pharmacy professionals and allied health care professionals about the Saskatchewan Biosimilars Initiative.
Speakers:
- Janice Norfield, BSP, medSask
- Chantal Mougeot, BSP, Drug Plan and Extended Benefits Branch, Ministry of Health.
Target Audience: All Saskatchewan Health Care providers are invited to attend.
Date: This session was recorded March 8, 2023.
Accredited by CPDPP: for 1.0 CEUs
Cost: n/a
Learning Objectives
At the end of the educational webinar, participants will be able to:
- Describe and differentiate biologic drugs and biosimilars.
- Explain the Saskatchewan Biosimilars Initiative.
- Summarize the pharmacist’s role in facilitating a transition to biosimilar insulin and how services are remunerated.
- Describe the role of primary care providers in facilitating the transition to biosimilar insulin.
- Outline important patient education information.
- Identify the impact of the nocebo effect and describe strategies on how to minimize it.